BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12526173)

  • 1. In vivo infection of mice by replication-competent MLV-based retroviral vectors.
    Bachrach E; Duch M; Pelegrin M; Dreja H; Pedersen FS; Piechaczyk M
    Methods Mol Med; 2003; 76():343-52. PubMed ID: 12526173
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of foamy virus vectors.
    Vassilopoulos G; Josephson NC; Trobridge G
    Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
    [No Abstract]   [Full Text] [Related]  

  • 3. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titer.
    Dubensky TW; Sauter SL
    Methods Mol Med; 2003; 76():309-30. PubMed ID: 12526171
    [No Abstract]   [Full Text] [Related]  

  • 5. A highly efficient gene delivery system derived from feline immunodeficiency virus (FIV).
    Sauter SL; Gasmi M; Dubensky TW
    Methods Mol Med; 2003; 76():405-32. PubMed ID: 12526177
    [No Abstract]   [Full Text] [Related]  

  • 6. Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses.
    Takeuchi Y; Simpson G; Vile RG; Weiss RA; Collins MK
    Virology; 1992 Feb; 186(2):792-4. PubMed ID: 1733113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-entry restriction of retroviral infections.
    Towers GJ; Goff SP
    AIDS Rev; 2003; 5(3):156-64. PubMed ID: 14598564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines.
    Scarpa M; Cournoyer D; Muzny DM; Moore KA; Belmont JW; Caskey CT
    Virology; 1991 Feb; 180(2):849-52. PubMed ID: 1989392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer to human pancreatic endocrine cells using viral vectors.
    Leibowitz G; Beattie GM; Kafri T; Cirulli V; Lopez AD; Hayek A; Levine F
    Diabetes; 1999 Apr; 48(4):745-53. PubMed ID: 10102690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.
    Stuhlmann H; Jaenisch R; Mulligan RC
    Mol Cell Biol; 1989 Jan; 9(1):100-8. PubMed ID: 2927389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
    Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993).
    Anderson WF; McGarrity GJ; Moen RC
    Hum Gene Ther; 1993 Jun; 4(3):311-21. PubMed ID: 8338878
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.
    Steidl S; Schüle S; Mühlebach MD; Stitz J; Boller K; Cichutek K; Schweizer M
    J Gen Virol; 2004 Mar; 85(Pt 3):665-678. PubMed ID: 14993652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.
    Seamon JA; Jones KS; Miller C; Roth MJ
    J Virol; 2002 Aug; 76(16):8475-84. PubMed ID: 12134052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
    Bender MA; Palmer TD; Gelinas RE; Miller AD
    J Virol; 1987 May; 61(5):1639-46. PubMed ID: 3502707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insertion mutation in the pol gene of Moloney murine leukemia virus results in temperature-sensitive pol maturation and viral replication.
    Tanese N; Roth M; Epstein H; Goff SP
    Virology; 1989 Jun; 170(2):378-84. PubMed ID: 2786280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a double-copy bicistronic retroviral vector for human gene therapy.
    Wiznerowicz M; Fong AZ; Hawley RG; Mackiewicz A
    Adv Exp Med Biol; 1998; 451():441-7. PubMed ID: 10026909
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication.
    Dang Q; Hu WS
    J Virol; 2001 Jan; 75(2):809-20. PubMed ID: 11134294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.